5Schuetz E G, Schinkel A H, Relling M V, et al. P - glycoprotein : a major determinant of rifampicin - inducible expression of cytochrome P4503A in mice and human. Proc Natl Acad Sci, 1996,93:4001.
6Fromm M F, Kauffmann H M, Fritz P, et al. The effect of rifampin treatment on intestinal expression of human MRP transporters . Am J Pathol, 2000, 157 : 1575.
7Fattinger K, Cattori V, Hagenbuch B, et al. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatpl and Oatp2. Hepatology,2000,32 : 82.
8Greiner B, Elchelbaum M, Fritz P, et al. The role of intestinal P - glyco-protein in the interaction of digoxin and rifampin. J Clin Invest, 1999, 104(2) :147.
9Niemi M, Bachman J T, Fromm M F, et al. Pharmacokinetic interactions with rifampicin :clinical relevance. Clin Pharmacokinet,2003,42:819.
10Suzuki H, Sugiyama Y. Role of metabolic engymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci, 2000,12:3.
